Blog Category: Information

U.S. cannabis rescheduling and workplace considerations

U.S. cannabis rescheduling and workplace considerations

A recent article published by JDP examined how the potential U.S. federal rescheduling of cannabis from a Schedule I to Schedule III drug in the United States may affect employer drug testing policies, workplace safety rules, and legal risk. While Donald Trump’s...

Subscribe to receive the latest news and updates